DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr Reddy's Laboratories (Pty) Ltd
02 2Adcock Ingram Limited
03 2Cipla Medpro (Pty) Ltd
04 2Equity Pharmaceuticals (Pty) Ltd
05 5Roche Products (Pty) Ltd
06 2Sandoz SA (Pty) Ltd
01 15Rituximab
01 14INF
02 1INJ
01 1BLITZIMA 100 mg
02 1BLITZIMA 500 mg
03 1MABTHERA SC 1400mg
04 1Mabthera 100Mg 10Ml
05 1Mabthera 500Mg 50Ml
06 1RISTOVA® 100
07 1RISTOVA® 500
08 1Redditux 100
09 1Redditux 500
10 1Rituximab 100 Cipla
11 1Rituximab 100 Equity
12 1Rituximab 500 Cipla
13 1Rituximab 500 Equity
14 1Rixathon 100mg/10ml
15 1Rixathon 500mg/50ml
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Redditux 100
Dosage Form : INF
Dosage Strength : 100 mg/10 ml
Packaging : 10X1 mg/10 ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Redditux 500
Dosage Form : INF
Dosage Strength : 500 mg/50 ml
Packaging : 50X1 mg/50 ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : BLITZIMA 100 mg
Dosage Form : INF
Dosage Strength : 100mg/10ml
Packaging : 10X2mg/10ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : BLITZIMA 500 mg
Dosage Form : INF
Dosage Strength : 500mg/50ml
Packaging : 50X1mg/50ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Rituximab 100 Cipla
Dosage Form : INF
Dosage Strength : 10010 mg/mL
Packaging : 2X110 mg/mL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Rituximab 500 Cipla
Dosage Form : INF
Dosage Strength : 50010 mg/mL
Packaging : 1X110 mg/mL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Rituximab 100 Equity
Dosage Form : INF
Dosage Strength : 100mg/10ml
Packaging : 10X2mg/10ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Rituximab 500 Equity
Dosage Form : INF
Dosage Strength : 500mg/50ml
Packaging : 50X1mg/50ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : RISTOVA® 100
Dosage Form : INF
Dosage Strength : 10mg/ml
Packaging : 10X2mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : RISTOVA® 500
Dosage Form : INF
Dosage Strength : 10mg/ml
Packaging : 50X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
